Wei Lin - 15 Jul 2021 Form 3 Insider Report for Erasca, Inc. (ERAS)

Role
Chief Medical Officer
Signature
/s/ Ebun S. Garner, Attorney-in-Fact
Issuer symbol
ERAS
Transactions as of
15 Jul 2021
Transactions value $
$0
Form type
3
Filing time
15 Jul 2021, 21:37:57 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ERAS Common Stock 313K 15 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ERAS Stock Option (Right to Buy) 15 Jul 2021 Common Stock 833K $3.36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 312,500 shares subject to repurchase by us, which are subject to vesting.
F2 25% of the shares subject to the options vest on January 11, 2022, the one-year anniversary of the vesting commencement date, and 1/48th of the shares subject to the option vest monthly thereafter.

Remarks:

Exhibit 24 - Power of Attorney